Results 11 to 20 of about 119,004 (251)

Bacterial Toxins, Current Perspectives

open access: yesToxins, 2020
Toxins are the major pathogenicity factors produced by numerous bacteria involved in severe diseases in humans and animals. Certain pathogenic bacteria synthesize only one toxin which is responsible for all the symptoms and outcome of the disease.
Michel R. Popoff
doaj   +2 more sources

Diffusion of Botulinum Toxins [PDF]

open access: yesTremor and Other Hyperkinetic Movements, 2012
Background: It is generally agreed that diffusion of botulinum toxin occurs, but the extent of the spread and its clinical importance are disputed.
Matthew A. Brodsky   +2 more
doaj   +2 more sources

Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity

open access: yesToxins, 2015
Mass spectrometry has recently become a powerful technique for bacterial identification. Mass spectrometry approaches generally rely upon introduction of the bacteria into a matrix-assisted laser-desorption time-of-flight (MALDI-TOF) mass spectrometer ...
Suzanne R. Kalb   +2 more
doaj   +2 more sources

FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. [PDF]

open access: yesToxins (Basel), 2020
In 2016, the American Academy of Neurology (AAN) published practice guidelines for botulinum toxin (BoNT) in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. This article, focusing on dystonia, provides context for these
Spiegel LL, Ostrem JL, Bledsoe IO.
europepmc   +2 more sources

Variability of Botulinum Toxins: Challenges and Opportunities for the Future. [PDF]

open access: yesToxins (Basel), 2018
Botulinum neurotoxins (BoNTs) are the most potent known toxins, and are therefore classified as extremely harmful biological weapons. However, BoNTs are therapeutic drugs that are widely used and have an increasing number of applications.
Rasetti-Escargueil C   +2 more
europepmc   +2 more sources

Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches. [PDF]

open access: yesToxins (Basel), 2019
International audienceBotulinum neurotoxin (BoNT) is produced by the anaerobic, Gram-positive bacterium Clostridium botulinum. As one of the most poisonous toxins known and a potential bioterrosism agent, BoNT is characterized by a complex mode of action
Rasetti-Escargueil C, Popoff MR.
europepmc   +2 more sources

The Structure and Classification of Botulinum Toxins

open access: yes, 2021
Botulinum neurotoxins (BoNTs) are a family of bacterial protein toxins produced by various Clostridium species. They are traditionally classified into seven major serotypes (BoNT/A-G).
Stenmark, Pål,   +2 more
core   +2 more sources

Harnessing the Membrane Translocation Properties of AB Toxins for Therapeutic Applications [PDF]

open access: yes, 2021
Over the last few decades, proteins and peptides have become increasingly more common as FDA-approved drugs, despite their inefficient delivery due to their inability to cross the plasma membrane.
Oksana A. Sergeeva   +2 more
core   +2 more sources

Domperidone Inhibits Clostridium botulinum C2 Toxin and Bordetella pertussis Toxin [PDF]

open access: yes, 2023
Bordetella pertussis toxin (PT) and Clostridium botulinum C2 toxin are ADP-ribosylating toxins causing severe diseases in humans and animals. They share a common translocation mechanism requiring the cellular chaperones Hsp90 and Hsp70, cyclophilins, and
Barth Holger   +6 more
core   +2 more sources

Entering neurons: botulinum toxins and synaptic vesicle recycling. [PDF]

open access: yes, 2006
Botulinum toxins are metalloproteases that act inside nerve terminals and block neurotransmitter release through their cleavage of components of the exocytosis machinery.
Matteoli M   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy